| Nucleoporin gene | Partner gene | Translocation | Domain or partner function | Disease | Reference |
|
NUP98 | HOXA9 | t(7; 11)(p15; p15) | HD | AML, MDS, CML, CMML | [99, 100, 104, 107, 108, 112, 214] | HOXA11 | t(7; 11)(p15; p15) | HD | AML, JMML | [215–218] | HOXA13 | t(7; 11)(p15; p15) | HD | AML | [215, 219] | HOXC11 | t(11; 12)(p15; q13) | HD | AML | [220, 221] | HOXC13 | t(11; 12)(p15; q13) | HD | AML | [222–224] | HOXD11 | t(2; 11)(q31; p15) | HD | AML | [223, 225] | HOXD13 | t(2; 11)(q31; p15) | HD | AML | [226–229] | HHEX | t(10; 11)(q23; p15) | HD | AML | [110] | PMX1 | t(1; 11)(q23; p15) | HD | AML, MDS | [230–232] | PMX2 | t(9; 11)(q34; p15) | HD | AML | [233] | POU1F1 | t(3; 11)(p11; p15) | HD | AML | [234] | GSX2 | t(4; 11)(q12; p15) | HD | MDS | [235] | PHF23 | t(11; 17)(p15; p13) | PHD | AML | [236] | JARID1A | t(11; 12)(p15; p13) | PHD | AML | [237, 238] | NSD1 | t(5; 11)(q35; p15) | PHD | AML, RA | [115, 116, 237, 239–244] | NSD3 | t(8; 11)(p11; p15) | PHD | AML | [245, 246] | MLL | inv(11)(p15q23) | PHD | AML | [117] | AF10 | t(10; 11)(p12; p15) | AT hook | MDS, CML | [235] | SETBP1 | t(11; 18)(p15; q12) | AT hook | T-ALL | [247] | HMGB3 | t(X; 11)(q28; p15) | DNA binding, bending | AML | [248] | TOP1 | t(11; 20)(p15; q12) | DNA topoisomerase 1 | AML, MDS | [249–253] | TOP2B | t(3; 11)(p24; p15) | DNA topoisomerase 1 | AML | [254] | DDX10 | inv(11)(p15q21–q23) | RNA helicase | AML, MDS, CML | [105, 255–258] | RAP1GDS1 | t(4; 11)(q21; p15) | RAS signalling | T-ALL | [259–261] | ADD3 | t(10; 11)(q25; p15) | Actin-binding, calmodulin-binding | T-ALL | [262] | ANKRD28 | t(3; 11)(p25; p15) | Ankyrin repeats | AML, MDS | [263] | LEDGF | t(9; 11)(p22; p15) | PWWP domain | AML, CML | [223, 264–267] | IQCG | t(3; 11)(q29q13; p15) del(3q29) | IQ motif, EF-hand binding | AML, T-ALL | [268] | RARG | t(11; 12)(p15; q13) | Nuclear hormone receptor | AML | [269] | CCDC28A | t(6; 11)(q24; p15) | Coiled-coil | AML, T-ALL | [270, 271] | LOC348801 | t(3; 11)(q12; p15) | Coiled-coil | AML | [272] |
|
|